Dr. J. Ova-One
Natural health product licensed in Canada
- Other names
- Dr. J. Fit-Ova
- Licence holder
- Holy Land Traditional Medications Inc.
- NPN or DIN-HM
- 80088476
- Status
- Active licence
- Licence date
- 27 September 2018
- Revision date
- 30 May 2024
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 30 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 40 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine E: up to 160 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- À vérifier
Zinc: up to 40 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Gelée Royale Source : Apis mellifera - sécrétion | 20 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 15 mg | 30,000 µg |
| Zinc Source : Oxyde de zinc | 20 mg | 40,000 µg |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl | 40 mg | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 80 mg | 160,000 µg |
| Vitamine B12 Source : Cyanocobalamine | 150 mcg | 300 µg |
| Folate Source : Acide folique | 50 mcg | Not calculated |
| Fer Source : Gluconate de fer (II) | 7 mg | 14,000 µg |
| Magnésium Source : Oxyde de magnésium | 100 mg | 200,000 µg |
| Vitex agnus-castus Source : Fruit Potency : 0.5 % Agnuside | 50 mg | Not calculated |
| L-arginine | 50 mg | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 1,000 mcg | 2,000 µg |
Non-medicinal ingredients
Phosphate dicalcique, Hypromellose, Stéarate de magnésium, Cellulose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 1 Comprimé | 2 days |
Uses authorised in Canada
Chasteberry, used in Herbal Medicine to help relieve premenstrual symptoms. Chasteberry, used in Herbal Medicine as a hormone normalizer and to help stabilize menstrual cycle irregularities. Chasteberry, used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes. Contains zinc to help in connective tissue formation and helps to maintain immune function. And Copper to help to produce and repair connective tissue. And Magnesium to help to maintain proper muscle function. Contains Royal Jelly and Vitamin E as a source of antioxidants (for the maintenance of good health) and Contains B6 to help in tissue formation, B12 & iron to help form red blood cells and and to help in their proper function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood pressure medication and if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen. Keep out of reach of children. There is enough drug in this package to seriously harm a child.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use immediately.
- Contre-indications
If you have a history of asthma or allergies, do not use this product. Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician.
Source
Official Health Canada record, licence 80088476
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging